UNSPSC 51141571: Phensuximide

This classification denotes an anticonvulsant agent with the molecular formula C11H11NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6WVL9C355G, chemically known as 2,5-pyrrolidinedione, 1-methyl-3-phenyl- but generally known as phensuximide, which bears US NIH Compound Identifier 6839. European Medicines Agency schedules Phensuximide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09783MIG.

UNSPSC 51141571 Phensuximide is a Commodity code that nominally designates pharmaceutical seizure-management medications, yet recent state and local procurement activity under this code shows minimal alignment with the code's stated scope. The single available recent opportunity—Seminole County, Florida's IFB for Naloxone and drug deactivation systems—addresses opioid-overdose response and harm-reduction supplies rather than phensuximide or related anticonvulsants. State and local governments appear to use this code infrequently or inconsistently for pharmaceutical procurement, and the mismatch between the code's pharmaceutical classification and the actual goods being solicited suggests either mis-tagging in the county's procurement system or limited recent activity under the true phensuximide commodity.

Seminole County, Florida is the only recent issuing body visible in current records. The IFB60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023, solicited 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford. Vendors were required to submit bids through the county's e-Procurement Portal, include all shipping and delivery costs in pricing, maintain drug-free workplace certification and E-Verify compliance, and provide evidence of workers' compensation, commercial general liability, and professional liability insurance. The contract structure includes a two-year initial term with a one-year renewal option and a three-month probationary period. No set-aside designations were specified, though potential FEMA funding introduced additional federal compliance requirements. Activity under this code remains too sparse to characterize a meaningful geographic or issuer-body pattern.